Together with other cytokines, TNF-α holds a central position within immune cell activation and tissue destruction, and the application of TNF-α-antibodies and other antagonistic molecules [51] is a novel therapeutic strategy in the treatment of colitis ulcerosa and/or Crohn's disease (reviewed by [7]). The gene discussed is TNF; the disease is Crohn disease.